Literature DB >> 32089020

Statins and muscle pain.

Joseph V Pergolizzi1, Flaminia Coluzzi2, Robert D Colucci1,3, Hanna Olsson4, Jo Ann LeQuang1, Jonathan Al-Saadi4, Peter Magnusson4,5.   

Abstract

Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are often reported from patients on statins. Muscle symptoms are frequently reported as adverse events associated with statin therapy.Areas covered: In the present narrative review, statin-associated muscle pain is discussed. It elucidates potential mechanisms and possible targets for management.Expert opinion: In general, the evidence in support of muscle pain caused by statins is in some cases equivocal and not particularly strong. Reported symptoms are difficult to quantify. Rarely is it possible to establish a causal link between statins and muscle pain. In randomized controlled trials, statins are well tolerated, and muscle-pain related side-effects is similar to placebo. There are also nocebo effects of statins. Exchange of statin may be beneficial although all statins have been associated with muscle pain. In some patients reduction of dose is worth trying, especially in primary prevention Although the benefits of statins outweigh potential risks in the vast majority of cases, careful clinical judgment may be necessary in certain cases to manage potential side effects on an individual basis.

Entities:  

Keywords:  Adverse events; cardiovascular disease; muscle pain; myalgia; side effects; statin

Mesh:

Substances:

Year:  2020        PMID: 32089020     DOI: 10.1080/17512433.2020.1734451

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  6 in total

1.  Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.

Authors:  Maranda S Cantrell; Jackson D Wall; Xinzhu Pu; Matthew Turner; Luke Woodbury; Ken Fujise; Owen M McDougal; Lisa R Warner
Journal:  Protein Expr Purif       Date:  2021-10-06       Impact factor: 1.650

Review 2.  Crocins for Ischemic Stroke: A Review of Current Evidence.

Authors:  Kiran Shahbaz; Dennis Chang; Xian Zhou; Mitchell Low; Sai Wang Seto; Chung Guang Li
Journal:  Front Pharmacol       Date:  2022-08-05       Impact factor: 5.988

3.  Effect of Spray Drying Conditions on Physical Properties of Panax notoginseng Saponin (PNS) Powder and the Intra-Batch Dissolution Variability of PNS Hydrophilic Matrix Tablet.

Authors:  Maorui Yang; Bing Xu; Xin Wang; Wanting Li; Junjie Cao; Wenjing Li; Yanjiang Qiao
Journal:  Drug Des Devel Ther       Date:  2021-03-30       Impact factor: 4.162

4.  Active Annotation in Evaluating the Credibility of Web-Based Medical Information: Guidelines for Creating Training Data Sets for Machine Learning.

Authors:  Aleksandra Nabożny; Bartłomiej Balcerzak; Adam Wierzbicki; Mikołaj Morzy; Małgorzata Chlabicz
Journal:  JMIR Med Inform       Date:  2021-11-26

Review 5.  Challenging Aspects to Precise Health Strategies in Native Hawaiian and Other Pacific Islanders Using Statins.

Authors:  Ligia M Watanabe; Lucia A Seale
Journal:  Front Public Health       Date:  2022-02-28

Review 6.  Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects.

Authors:  Ying Hu; Xingjuan Chen; Mu Hu; Dongwei Zhang; Shuo Yuan; Ping Li; Ling Feng
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.